Recombinant human eosinophii-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus

Journal of Infectious Diseases

Volumn 177, Issue 6, 1998, Pages 1458-1464

  Domachowske, Joseph B ^b   Dyer, Kimberly D ^b   Bonville, Cynthia A ^b   Rosenberg, Helene F ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTOXIN; RECOMBINANT PROTEIN; RIBONUCLEASE; ANTIVIRUS AGENT; EOSINOPHIL PROTEIN X; HYBRID PROTEIN; PANCREATIC RIBONUCLEASE; PLACENTAL PEPTIDE HORMONE; PLACENTAL RIBONUCLEASE INHIBITOR; PROTEIN;

ARTICLE; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS RESISTANCE; AMINO ACID SEQUENCE; ANIMAL; CATTLE; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; MOLECULAR GENETICS; PHYSIOLOGY; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; CATTLE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; HUMANS; MOLECULAR SEQUENCE DATA; PLACENTAL HORMONES; PROTEINS; RECOMBINANT FUSION PROTEINS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RIBONUCLEASE, PANCREATIC; RIBONUCLEASES; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED;

EID: 0031596883     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515322     Document Type: Article

References (19)

1. Sher A, Coffman RL, Hieny S, Scott P, Cheever AW. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci USA 1990;87:61-5.
2. Sher A, Coffman RL, Hieny S, Cheever AW. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J Immunol 1990;145:3911-6.
3. + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996;4:15-24.
4. Freeman GL, Tominaga A, Takatsu K, Secor WE, Colley DG. Elevated innate peripheral blood eosinophilia fails to augment irradiated cercarial vaccine-induced resistance to Schistosoma mansoni in IL-5-transgenic mice. J Parasitol 1995;81:1010-1.
5. Herndon FJ, Kayes SG. Depletion of eosinophils by anti-IL-5 monoclonal antibody treatment of mice infected with Trichinella spiralis does not alter parasite burden or immunologic resistance to reinfection. J Immunol 1992;149:3642-7.
6. Spry CJF. Eosinophils. A comprehensive review and guide to the scientific and medical literature. Oxford, UK: Oxford University Press, 1988.
7. Hamann KJ, Barker RL, Ten RM, Gleich GJ. The molecular biology of eosinophil granule proteins. Int Arch Allergy Appl Immunol 1991;94:202-9.
8. Slifman NR, Loegering DA, McKean DJ, Gleich GJ. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol 1986;137:2913-7.
9. Gullberg H, Widegren B, Amason U, Egesten A, Olsson I. The cytotoxic eosinophil cationíc protein (ECP) has ribonuclease activity. Biochem Biophys Res Commun 1986;139:1239-42.
10. Gleich GJ, Loegering DA, Bell MP, Checkel JL, Ackerman SJ, McKean DJ. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci USA 1986;83:3146-50.
11. Rosenberg HF, Ackerman SJ, Tenen DG. Human eosinophil cationic protein: molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. J Exp Med 1989;170:163-76.
12. Rosenberg HF, Tenen DG, Ackerman SJ. Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. Proc Natl Acad Sci USA 1989;86:4460-4.
13. Barker RL, Loegering DA, Ten RM, Hamann KJ, Please LR, Gleich GJ. Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases. J Immunol 1989;143:952-5.
14. Hamann KJ, Barker RL, Loegering DA, Gleich GJ. Sequence of human eosinophil-derived neurotoxin cDNA: identity of deduced amino acid sequence with human nonsecretory ribonucleases. Gene 1989;83:161-7.
15. Rosenberg HF, Dyer KD, Tiffany HL, Gonzalez M. Rapid evolution of a unique family of primate ribonuclease genes. Nature Genet 1995;10:219-23.
16. Durack DT, Sumi SM, Klebanoff SJ. Neurotoxicity of human eosinophils. Proc Natl Acad Sci USA 1979;76:1443-7.
17. Durack DT, Ackerman SJ, Loegering DA, Gleich GJ. Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci USA 1981;78:5165-9.
18. Newton DL, Walbridge S, Mikulski SJ, et al. Toxicity of an anti-tumor ribonuclease to Purkinje neurons. J Neurosci 1994;14:538-44.
19. Sorrentino S, Glitz DG, Hamann KJ, Loegering DA, Checkel JL, Gleich GJ. Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity. J Biol Chem 1994;267:14859-65.